1 year return (CAGR)
-1.87%
Arbutus Biopharma Corp Exchange (NASDAQ, USD)
ABUS
4.20
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
33.89%
5 year return (CAGR)
0.29%
10 year return (CAGR)
3.88%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
832.04M
Price/Sales
4.58
Ent value
828.17M
Price/Book
3.22
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
5.44
PEG
-
Forward P/E
-
EPS growth
-26.95%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.22 |
| Daily high | 4.26 |
| Daily low | 4.18 |
| Daily Volume | 1.41M |
| All-time high | 30.94 |
| 1y analyst estimate | 5.36 |
| Beta | 0.62 |
| EPS (TTM) | 0.78 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ABUS | S&P500 | |
| Current price drop from All-time high | -86.43% | -1.76% |
| Highest price drop | -97.19% | -56.47% |
| Date of highest drop | 9 Oct 2019 | 9 Mar 2009 |
| Avg drop from high | -75.65% | -10.65% |
| Avg time to new high | 143 days | 12 days |
| Max time to new high | 3177 days | 1805 days |
News
